Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 4
2012 2
2013 7
2014 4
2015 7
2016 6
2017 6
2018 8
2019 9
2020 13
2021 12
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Malignant Mesothelioma.
Pouliquen DL, Kopecka J. Pouliquen DL, et al. Among authors: kopecka j. Cancers (Basel). 2021 Jul 9;13(14):3447. doi: 10.3390/cancers13143447. Cancers (Basel). 2021. PMID: 34298661 Free PMC article.
Mitochondria-Targeted Drug Delivery.
Kopecka J. Kopecka J. Pharmaceutics. 2022 Jan 13;14(1):178. doi: 10.3390/pharmaceutics14010178. Pharmaceutics. 2022. PMID: 35057073 Free PMC article.
Hypoxia as a driver of resistance to immunotherapy.
Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, Riganti C. Kopecka J, et al. Drug Resist Updat. 2021 Dec;59:100787. doi: 10.1016/j.drup.2021.100787. Epub 2021 Nov 18. Drug Resist Updat. 2021. PMID: 34840068 Review.
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer.
Salaroglio IC, Mungo E, Gazzano E, Kopecka J, Riganti C. Salaroglio IC, et al. Among authors: kopecka j. Int J Mol Sci. 2019 May 21;20(10):2505. doi: 10.3390/ijms20102505. Int J Mol Sci. 2019. PMID: 31117237 Free PMC article. Review.
71 results